Orphan Medicines Launch Excellence: Sustaining Launch Success
June 13, 2019
3:00PM - 4:00PM

Successfully launching orphan medicines will become even more important over the next five years as more patients with rare diseases have treatments available and the growing number of disease registries, increases public and policy maker awareness.

Join our webinar on Thursday 13th June from 15:00-16:00 BST and look at how pharmaceutical companies can optimise all the activities needed to take orphan medicines from clinical development to commercialisation, including:

  • The three fundamental orphan medicine launch excellence challenges
  • The ways in which companies launching orphan medicines can learn from excellence in mainstream launches
  • The specific areas of focus that are crucial for orphan medicines launch excellence


  • Angela McFarlane, Market Development Director, IQVIA
  • Sarah Rickwood, Vice President, European Thought Leadership, IQVIA
  • Peter Meeus, European Orphan Medicines Commercial Excellence Executive
  • Paul Tunnah, CEO, pharmaphorum (moderator)
Contact Us
Contact Us

Email Us

Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?

Call Us

We're available during standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.

Media Inquiries

Please note that forms have been updated on SC9 PROD, it may be good to update the SC9 DEV forms with SC9 PROD.